Biosimilars London 2017

DALI presented its user-friendly SAN™ product line in the 10^th Biosimilars & Follow-On Biologics Congregation, May 9-10, 2017.

David, DALI’s CEO and Co-founder, spoke about Partnering with biosimilar and generic companies for injection devices.